JAK2 and idiopathic pulmonary fibrosis: Likewise, IPF patients exhibited enhanced levels of phosphorylated JAK2-STAT3 in lung tissues while dual inhibition of phosphorylated JAK2-STAT3 reduced lung fibrosis in mice with bleomycin challenge [142].